Doxepin Drug Classification
Doxepin is a tricyclic antidepressant (TCA), specifically a dibenzoxepin tricyclic compound. 1
Primary Classification
Doxepin belongs to the tricyclic antidepressant (TCA) class, which is a family of psychotherapeutic agents characterized by their three-ring chemical structure. 2 More specifically, it is classified as a dibenzoxepin derivative, making it the first of this particular family of tricyclic compounds. 1
Mechanism of Action
The drug works primarily by:
- Blocking reuptake of norepinephrine at nerve terminals, preventing its deactivation at synapses 1
- Blocking sodium ion channels, which contributes to its analgesic effects when used topically 2
- Exhibiting anticholinergic, antiserotonin, and antihistamine effects on smooth muscle 1
Clinical Context and Alternative Uses
While doxepin's primary classification is as a tricyclic antidepressant, it has multiple clinical applications beyond depression:
- Low-dose formulations (3 mg and 6 mg) are FDA-approved specifically for insomnia treatment, where it functions as a heterocyclic hypnotic agent 3
- When used for pain management (particularly oral mucositis), it acts as a topical analgesic through sodium channel blockade 2
- In irritable bowel syndrome, it is categorized as a gut-brain neuromodulator rather than simply an antidepressant 4
Important Distinction from Other Drug Classes
Doxepin is not:
- A central nervous system stimulant 1
- A monoamine oxidase inhibitor (MAOI) 1
- A selective serotonin reuptake inhibitor (SSRI) 5
- A serotonin-norepinephrine reuptake inhibitor (SNRI) 5
Therapeutic Drug Monitoring Classification
In therapeutic drug monitoring guidelines, doxepin is grouped with other TCAs including amitriptyline, imipramine, clomipramine, and desipramine, with its active metabolite demethyldoxepin requiring monitoring. 6